1.
Fogarty P, Seggewiss R, McCloskey D, Boss C, Dunbar C, Rick M. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura. Haematologica 2006; 91(2):277-278.